There were less than 10 deaths from cancer reported in Wyoming in the week ending Oct. 15, making up less than 23.3% of total deaths by all causes in Wyoming.
Deaths after taking the COVID-19 vaccine total 8,214 across the US, with 23 deaths being in Wyoming, according to the National Vaccine Information Center.
There were less than 10 deaths from cerebrovascular diseases reported in Wyoming in the week ending Oct. 15, making up less than 23.3% of total deaths by all causes in Wyoming.
There were less than 10 deaths from chronic lower respiratory diseases reported in Wyoming in the week ending Oct. 15, making up less than 23.3% of total deaths by all causes in Wyoming.
There were 18 deaths with heart disease listed as the underlying cause reported in Wyoming during the week ending Oct. 29, 2022, a 20% increase over the previous week.
Wyoming's death count did not exceed the upper threshold of death expectancy during the week ending Oct. 15, according to the Centers for Disease Control and Prevention.
The average VA Purchase Loan amount for Wyoming in the fourth quarter of fiscal year 2022 was $343,784, according to figures provided by the Veterans Affairs Home Loans Index.
There were 17 deaths with cancer listed as the underlying cause reported in Wyoming during the week ending Oct. 29, 2022, a 30.8% increase over the previous week.
There were less than 10 deaths from Alzheimer's disease reported in Wyoming in the week ending Oct. 15, making up less than 23.3% of total deaths by all causes in Wyoming.
There were less than 10 deaths from diabetes mellitus reported in Wyoming in the week ending Oct. 15, making up less than 23.3% of total deaths by all causes in Wyoming.
There were less than 10 deaths from nephritis, nephrotic syndrome and nephrosis reported in Wyoming in the week ending Oct. 15, making up less than 23.3% of total deaths by all causes in Wyoming.
Improvements to Cheek-Sparger Road are on the horizon! The City of Colleyville is heading up this project and while there are no definitive start dates yet, here’s what’s to come: